AstraZeneca has agreed to acquire CinCor Pharma in a deal that could exceed $1 billion. CinCor Pharma develops treatments for resistant hypertension and chronic kidney disease,...
S&P Global's 2022 review had a record 1,728 companies participating, a 9% increase from 2021. The review was based on a combination of companies' self-disclosures and...
Pharma Mar has decided to liquidate its diagnostic subsidiary Genomics, as part of their strategy to focus on their core activity of drug development and marketing....
Recently, Musk sold a part of his own Tesla stock to fund the Twitter project, as CNBC recalled. Searching Twitter for content on "Tesla stock" yields...
On July 13th, 2022, the new call for the granting of subsidies for the year to Personalized Precision Medicine Research Projects for €81.5 million was published. Likewise,...
As far as real estate is concerned, UpsideTown aims to select transactions with a diversified risk profile, asset class, and geographic distribution. A specific business line...
The Ministry will launch a national open science strategy, with support for institutions to publish their research in the open, as well as data, methods, or...
Genesis Biomed has helped its clients close a total of 19 rounds of financing since its incorporation, participating in the launch of twelve start-ups and spin-offs....
More than 60% of the €1.27 billion allocated to R&D in 2021 was devoted to clinical trials (€789 million), where Spain plays a prominent international role,...
The French pharmaceutical group Sanofi explained that the price expectations of the target did not match its criteria. Some analysts had a mixed opinions on this...